BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Diagnosis
26 results:

  • 1. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
    Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
    [No Abstract]    [Full Text] [Related]  

  • 2. Current situation of fungal diseases in Eritrea.
    Werkneh S; Orefuwa E; Denning DW
    Mycoses; 2022 Aug; 65(8):806-814. PubMed ID: 35633079
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis.
    Perek S; Khatib A; Izhaki N; Khalaila AS; Brenner B; Horowitz NA
    Eur J Intern Med; 2022 Jul; 101():68-75. PubMed ID: 35527180
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
    Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
    J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Incidence of Acute Myeloid leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
    Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The Relationship between ASXL2 and ZBTB7A Gene Mutations and Prognosis in Patients with Acute Myeloid leukemia].
    Cao HQ; Tuo JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):450-455. PubMed ID: 33812414
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Health Care Cost Associated With Contemporary Chronic Myelogenous leukemia Therapy Compared With That of Other Hematologic Malignancies.
    Wilkes JJ; Lyman GH; Doody DR; Chennupati S; Becker LK; Morin PE; Winestone LE; Henk HJ; Chow EJ
    JCO Oncol Pract; 2021 Mar; 17(3):e406-e415. PubMed ID: 32822255
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case Report of acute myeloid leukemia with "WT1, atrx, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
    Zhu H; Yang B; Liu J; Wu W; Ling Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18888. PubMed ID: 32011516
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Secondhand smoke: A new and modifiable prognostic factor in childhood acute lymphoblastic leukemias.
    Cárceles-Álvarez A; Ortega-García JA; López-Hernández FA; Fuster-Soler JL; Ramis R; Kloosterman N; Castillo L; Sánchez-Solís M; Claudio L; Ferris-Tortajada J
    Environ Res; 2019 Nov; 178():108689. PubMed ID: 31479979
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
    Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
    Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
    Mato AR; Nabhan C; Thompson MC; Lamanna N; Brander DM; Hill B; Howlett C; Skarbnik A; Cheson BD; Zent C; Pu J; Kiselev P; Goy A; Claxton D; Isaac K; Kennard KH; Timlin C; Landsburg D; Winter A; Nasta SD; Bachow SH; Schuster SJ; Dorsey C; Svoboda J; Barr P; Ujjani CS
    Haematologica; 2018 May; 103(5):874-879. PubMed ID: 29419429
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study.
    Belle FN; Weiss A; Schindler M; Goutaki M; Bochud M; Zimmermann K; von der Weid N; Ammann RA; Kuehni CE
    Am J Clin Nutr; 2018 Jan; 107(1):3-11. PubMed ID: 29381792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013.
    Norwood MS; Lupo PJ; Chow EJ; Scheurer ME; Plon SE; Danysh HE; Spector LG; Carozza SE; Doody DR; Mueller BA
    PLoS One; 2017; 12(6):e0179006. PubMed ID: 28594943
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.
    Geissler J; Sharf G; Bombaci F; Daban M; De Jong J; Gavin T; Pelouchova J; Dziwinski E; Hasford J; Hoffmann VS
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1167-1176. PubMed ID: 28289895
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research database.
    Stenehjem DD; Albright F; Kuo KL; Raimundo K; Bauer H; Shami PJ; Deininger MW; Chen L; Brixner DI
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1113-21. PubMed ID: 25099443
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors.
    Marks DI; Woo KA; Zhong X; Appelbaum FR; Bachanova V; Barker JN; Brunstein CG; Gibson J; Kebriaei P; Lazarus HM; Olsson R; Perales MA; Pidala J; Savani B; Rocha V; Eapen M
    Haematologica; 2014 Feb; 99(2):322-8. PubMed ID: 24056817
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical analysis on adult acute T-lymphoblastic leukemia].
    Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions.
    Perseghin P; Terruzzi E; Dassi M; Baldini V; Parma M; Coluccia P; Accorsi P; Confalonieri G; Tavecchia L; Verga L; Ravagnani F; Iacone A; Pogliani EM; Pioltelli P
    Transfus Apher Sci; 2009 Aug; 41(1):33-7. PubMed ID: 19540167
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival outcome in childhood ALL: experience from a tertiary care centre in North India.
    Kulkarni KP; Marwaha RK; Trehan A; Bansal D
    Pediatr Blood Cancer; 2009 Aug; 53(2):168-73. PubMed ID: 19405133
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.